BioSpectrum, Wednesday, March 3, 2010
Moleac Pte Ltd has been granted the Emerging Company of the Year 2010 Award by BioSpectrum. With an intention to address a therapeutic gap in stroke recovery Moleac introduced in the market NeuroAiD, the first medicine that brings faster and complete recovery for stroke patients. The approach adopted by Moleac turned out not only to be innovative but also highly efficient in terms of products commercialization. In a short period since its launch, NeuroAiD has becomes a treatment with global reach, witnessing considerable geographic expansion outside Singapore to many countries in the Asia Pacific region, the Middle East, Europe and the US.
Mr. David Picard, CEO of Moleac, receiving the BioSpectrum Emerging Company of the Year 2010 during ceremony held on Friday, March 12/2010 at Fort Canning Singapore.
